Studies with in-vivo, in-vitro treatment of osmotin also revealed its adiponectin's memetic effect toward obesity, diabetes and related fatty liver, cardiovascular diseases (183–186). The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.